Updated clinical data may significantly impact... - CLL Support

CLL Support

22,366 members38,469 posts

Updated clinical data may significantly impact treatment of CLL - Jeff Sharman

AussieNeil profile image
AussieNeilAdministrator
0 Replies

Here is yet another video interview with Dr Jeff Sharman about how information presented at ASH2014 is anticipated to impact CLL treatment. Here he discusses the impact of idelalisib and ibrutinib on the treatment of relapsed patients and the relevance of FCR treatment in the older population:

healio.com/hematology-oncol...

Neil

Written by
AussieNeil profile image
AussieNeil
Administrator
To view profiles and participate in discussions please or .
Read more about...

You may also like...

The CLL Treatment Revolution - Jeff Sharman

short article on the CLL treatment revolution for relapsed CLL by Dr Jeff Sharman for Clinical Care...

ASH 2012 Interview: Dr Jeff Sharman \"Why New CLL Treatments Supersede FCR\"

patientpower.info/video/an-expert-s-perspective-why-new-cll-treatments-supersede-fcr Some quotes...

How do changes in diet affect CLL treatment? Are supplements safe to use? CLL experts Dr. Michael Keating and Dr. Jeff Sharman respond

effects of diet on CLL from the well respected CLL specialists Drs Keating and Sharman. Dr...

Dr Sharman's survey to assess the CLL community's understanding of new treatments is now closed

Dr Jeff Sharman is curious to understand what people know / think they know about the new drugs...

Dr Jeff Sharman - How I Treat My Patients With CLL Who Are Fit or Otherwise Healthy

patients with CLL are not suitable for intensive chemoimmunotherapy with FCR, this population...